Date:11/10/2010

s=s_gi(s_account);s.linkTrackVars='prop5,eVar3,prop15,prop16,prop49,events';s.linkTrackEvents='event12';s.prop5='share it release';s.eVar3=s.prop5; s.prop15='107048253';s.prop16='CrowdFactory_Share';s.prop5+='_'+s.prop16;s.prop49=s.pageName;s.events='event12';s.tl(this,'o','CrowdFactory_Share'); }); cf_jq(".cf_dialog_footer button").live("mouseup", function (){ var socialText = this.innerHTML.replace("Post to ", ""); /*s.linkTrackVars='eVar3,prop15,prop16'; s.linkTrackEvents='None'; s.prop16='CrowdFactory_'+socialText; s.eVar3=s.prop16; s.prop15='Test'; //Newsrelease id s.tl(this,'o', 'CrowdFactory_'+socialText);*/ var s=s_gi(s_account);s.linkTrackVars='prop5,eVar3,prop15,prop16,prop49,events';s.linkTrackEvents='event12';s.prop5='share it release';s.eVar3=s.prop5; s.prop15='107048253';s.prop16='CrowdFactory_'+socialText;s.prop5+='_'+s.prop16;s.prop49=s.pageName;s.events='event12';s.tl(this,'o','CrowdFactory_'+socialText); }); });  

BASEL, Switzerland, Nov. 10 /PRNewswire/ - Neuro-Biotech Corporation (PINKSHEET: MRES) (OTCQB: MRES)

Neuro-Biotech Corp. is currently actively working towards the commercialization of natural products called "Neuroceuticals®", that are specially designed to restore the nervous system equilibrium and improve the state of health as well as the quality of life of people affected by stress-related disorders.

Our "Neuroceuticals®" respect international established quality standards (USP, EP and JP) in regards with purity, strength, and consistency of the products for human consumption.

According with our licences, we have a portfolio of four (4) innovative and selective products.

Neuro-Relax®
A protein based supplement that favours the sleep's quality, decreases the anxiety and nervous pressure, improves general anxiety, anxious disorders, physical, emotional and mental stress and has a tranquilizing and soothing effect

Neuro-Learn®
An adaptogene
'/>"/>

SOURCE Neuro-Biotech Corp. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8
Related biology technology :

1. Mr Claude Poulin nominated as President and CEO of Neuro-Biotech Corp.
2. Neuro-Biotechs Solution for a Doctor near You: Early Detection for Alzheimers and Chronic Fatigue Syndrome!
3. NEURO-BIOTECH DISCLOSES ITS LIST OF LICENSES
4. NEURO-BIOTECH CORPORATION: Updates and latest developments
5. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
6. InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008
7. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2008 on September 9, 2008
8. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
9. Aegis Analytical Corp. Showcases Discoverant at Inaugural Venture Capital in the Rockies Fall
10. BioElectronics Corp. Announces $400,000 in New Orders From the Middle East
11. BioSpecifics Technologies Corp. Announces Appointment of Dr. Matthew Geller to Board of Directors